Uquifa India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -15.20%
(FY 2023)
- Profit 114.76%
(FY 2023)
- Ebitda 241.76%
(FY 2023)
- Net Worth 234.40%
(FY 2023)
- Total Assets 8.50%
(FY 2023)
About Uquifa India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Varalwar and Saurabh Gurnurkar serve as directors at the Company.
- CIN/LLPIN
U24304TG2017FTC118240
- Company No.
118240
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
12 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Uquifa India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Varalwar  | Nominee Director | 12-Jul-2017 | Current |
| Saurabh Gurnurkar | Nominee Director | 12-Jul-2017 | Current |
Financial Performance and Corporate Structure Insights of Uquifa India.
Uquifa India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.2% decrease. The company also saw a substantial improvement in profitability, with a 114.76% increase in profit. The company's net worth Soared by an impressive increase of 234.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uquifa India?
In 2023, Uquifa India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Atri Pharma Research (India) Private LimitedActive 15 years 10 months
Santosh Varalwar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Uquifa India?
Uquifa India has a workforce of 28 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uquifa India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uquifa India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
